Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,980Revenue (TTM) $M7,517Net Margin (%)10.0Altman Z-Score3.2
Enterprise Value $M14,780EPS (TTM) $5.2Operating Margin %19.0Piotroski F-Score8
P/E(ttm)15.0Beneish M-Score-2.4Pre-tax Margin (%)15.7Higher ROA y-yY
Price/Book2.410-y EBITDA Growth Rate %6.2Quick Ratio1.3Cash flow > EarningsY
Price/Sales1.55-y EBITDA Growth Rate %4.3Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow17.4y-y EBITDA Growth Rate %13.9ROA % (ttm)7.4Higher Current Ratio y-yY
Dividend Yield %2.0PEG3.5ROE % (ttm)16.7Less Shares Outstanding y-yY
Payout Ratio %31.0Shares Outstanding M141ROIC % (ttm)11.6Gross Margin Increase y-yY

Gurus Latest Trades with DGX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DGXDavid Dreman 2016-03-31 Reduce-0.12%$60.54 - $72.26
($67.03)
$ 77.6216%Reduce -28.32%14,059
DGXChris Davis 2016-03-31 Reduce-0.08%$60.54 - $72.26
($67.03)
$ 77.6216%Reduce -7.69%3,314,772
DGXJohn Rogers 2016-03-31 Add0.05%$60.54 - $72.26
($67.03)
$ 77.6216%Add 7.77%747,094
DGXJoel Greenblatt 2016-03-31 Reduce-0.02%$60.54 - $72.26
($67.03)
$ 77.6216%Reduce -7.79%249,221
DGXCharles Brandes 2016-03-31 Reduce-0.01%$60.54 - $72.26
($67.03)
$ 77.6216%Reduce -3.73%162,685
DGXJoel Greenblatt 2015-12-31 Reduce-0.2%$61.58 - $72.11
($67.4)
$ 77.6215%Reduce -54.96%270,275
DGXChris Davis 2015-12-31 Reduce-0.16%$61.58 - $72.11
($67.4)
$ 77.6215%Reduce -14.58%3,590,857
DGXDavid Dreman 2015-12-31 Reduce$61.58 - $72.11
($67.4)
$ 77.6215%Reduce -1.51%19,614
DGXCharles Brandes 2015-12-31 Reduce$61.58 - $72.11
($67.4)
$ 77.6215%Reduce -0.84%168,985
DGXJohn Rogers 2015-12-31 Reduce$61.58 - $72.11
($67.4)
$ 77.6215%Reduce -0.36%693,253
DGXChris Davis 2015-09-30 Reduce-0.2%$60.51 - $74.58
($69.9)
$ 77.6211%Reduce -15.59%4,203,791
DGXJoel Greenblatt 2015-09-30 Add0.19%$60.51 - $74.58
($69.9)
$ 77.6211%Add 113.30%600,031
DGXJohn Rogers 2015-09-30 Add0.09%$60.51 - $74.58
($69.9)
$ 77.6211%Add 19.84%695,732
DGXDavid Dreman 2015-09-30 Reduce$60.51 - $74.58
($69.9)
$ 77.6211%Reduce -0.29%19,914
DGXCharles Brandes 2015-09-30 Reduce$60.51 - $74.58
($69.9)
$ 77.6211%Reduce -1.11%170,422
DGXT Rowe Price Equity Income Fund 2015-06-30 Sold Out -0.49%$69.89 - $79.6
($73.88)
$ 77.625%Sold Out0
DGXJoel Greenblatt 2015-06-30 Add0.14%$69.89 - $79.6
($73.88)
$ 77.625%Add 395.39%281,305
DGXJohn Rogers 2015-06-30 Add0.05%$69.89 - $79.6
($73.88)
$ 77.625%Add 12.52%580,555
DGXChris Davis 2015-06-30 Reduce-0.02%$69.89 - $79.6
($73.88)
$ 77.625%Reduce -1.74%4,980,482
DGXDavid Dreman 2015-06-30 Reduce-0.01%$69.89 - $79.6
($73.88)
$ 77.625%Reduce -7.34%19,971
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DGX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BRITELL JENNE KDirector 2016-05-12Sell8,000$75.682.56view
Cunningham EverettSVP, Commercial 2016-05-09Sell56,312$76.261.78view
Cunningham EverettSVP, Commercial 2016-05-06Sell50,447$762.13view
Doherty Catherine T.SVP, Clin. Franchise Solutions 2016-04-25Sell29,550$74.454.26view
BALDWIN JOHN C MDDirector 2015-08-12Sell2,266$727.81view
ZIEGLER JOHN BDirector 2015-08-06Sell2,200$74.354.4view
PREVOZNIK MICHAEL ESVP & General Counsel 2015-03-03Sell3,261$71.169.08view
PREVOZNIK MICHAEL ESVP & General Counsel 2015-02-17Sell488$71.418.7view
GUINAN MARKSenior Vice President & CFO 2015-02-17Sell280$71.748.2view
STANZIONE DANIELDirector 2015-02-11Sell8,000$70.979.37view

Press Releases about DGX :

Quarterly/Annual Reports about DGX:

News about DGX:

Articles On GuruFocus.com
Royce Special Equity Multi-Cap Fund Mar 22 2016 
Baron Growth Fund New Purchases Part 3 Feb 08 2016 
Popular Guru Stocks With High, Growing Yield Feb 03 2016 
The Best Companies of the Medical Industry – September 2015 Sep 25 2015 
Brian Rogers Buys Occidental Petroleum, Tyco In Q2 Jul 16 2015 
Vermillion (VRML) Ovarian Cancer Test Mega-deal; Papa Murphy's Holdings (FRSH) and Wix (WIX) Strong Mar 18 2015 
Charles Brandes' Top Buys During Q4 Feb 11 2015 
A Look at John Hussman's Recent Additions to His Portfolio Feb 06 2015 
DGX: A Healthy Diagnosis Oct 08 2014 
The Top Five Guru-Held Mid-Cap Stocks of Q2 Sep 04 2014 

More From Other Websites
The stocks fighting Zika May 24 2016
QUEST DIAGNOSTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 23 2016
Quest Diagnostics Announces Proposed Senior Notes Offering May 23 2016
8:43 am Quest Diagnostics announces $500 mln aggregate principal amount of senior notes in a public... May 23 2016
Quest Diagnostics Announces Proposed Senior Notes Offering May 23 2016
QUEST DIAGNOSTICS INC Files SEC form 8-K, Other Events May 20 2016
Theranos' Last Defense Crumbles May 19 2016
Quest Diagnostics (DGX) Divests Focus, Cuts Sales View May 19 2016
QUEST DIAGNOSTICS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial... May 18 2016
Quest Diagnostics Dividend Provides 2.10% Yield May 18 2016
Quest Diagnostics Declares Quarterly Cash Dividend May 18 2016
Quest Diagnostics Declares Quarterly Cash Dividend May 18 2016
Quest Diagnostics Completes Effort to Refocus on Diagnostic Information Services; Updates 2016... May 18 2016
Quest Diagnostics Completes Effort to Refocus on Diagnostic Information Services; Updates 2016... May 18 2016
DiaSorin S.p.A. Completes Acquisition of the Focus Diagnostics' Molecular and Immunoassay Product... May 13 2016
DiaSorin S.p.A. Completes Acquisition of the Focus Diagnostics' Molecular and Immunoassay Product... May 13 2016
QUEST DIAGNOSTICS INC Financials May 03 2016
Why Quest Diagnostics’ Five Point Business Strategy Matters in 2016 May 02 2016
These 5 Rocket Stocks Look Ready for Blastoff in May May 02 2016
First widely available Zika test OK'd for emergency use Apr 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)